Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
clinical trials
fda
3
×
life sciences
national blog main
boston top stories
deals
investing
480 biomedical
akouos
arsenal medical
astellas pharmaceuticals
biotech ipos
bob langer
california institute for biomedical research
chronic rhinosinusitis
covid-19
decibel therapeutics
drug delivery
dyne therapeutics
frequency therapeutics
genzyme
george whitesides
harvard university
hearing loss
inflammation
ipo
jeffrey karp
keros therapeutics
lyra therapeutics
medical device
metacrine
mometasone furorate
multiple sclerosis
myotonic dystrophy type 1
nonalcoholic steatohepatitis
north bridge venture partners
oric pharmaceuticals
What
developing
3
×
ipo
therapeutics
3
×
company
drug
medicines
million
raised
treat
affects
americans
approved
biotech
brings
date
debut
disorders
dyne
dyne’s
fda
frequency
genetic
hearing
late
loss
lyra
markets
meds
millions
muscle
muscular
new
nose
noses
persistently
plans
preclinical
public
raises
rare
Language
unset
Current search:
developing
×
therapeutics
×
fda
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds